Senators Slam GSK, FDA On Avandia Safety
Senators have blasted GlaxoSmithKline PLC for not alerting patients to potential cardiac risks associated with diabetes drug Avandia, and questioned what the FDA has done to ensure the safety of patients...To view the full article, register now.
Already a subscriber? Click here to view full article